Medulloblastoma: Systemic Chemotherapy and Future Applications of Chemoradiotherapy
Julia Hayden, Paul Rava(UMass Memorial Health Care), Eric C. Ko(UMass Memorial Health Care), Naheed Usmani(University of Massachusetts Chan Medical School), Nura El‐Haj, Maryann Bishop‐Jodoin(Health Insurance Review and Assessment Service), Koren Smith(University of Massachusetts Chan Medical School), Fran Laurie(University of Massachusetts Chan Medical School), Matthew Iandoli(Calista Therapeutics (United States)), Stefanie Lowas(Monroe Carell Jr. Children's Hospital)
Cited by 0
Related Papers
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
|Journal of Clinical Oncology|2014|394
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.
|International Journal of Radiation Oncology*Biology*Physics|2001|213
A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346
|International Journal of Radiation Oncology*Biology*Physics|1998|207